Progression-free survival ratio as end point for phase II trials in advanced solid tumors

J Clin Oncol. 2011 May 20;29(15):e451-2; author reply e453. doi: 10.1200/JCO.2010.34.0380. Epub 2011 Apr 4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Clinical Trials, Phase I as Topic / methods*
  • Disease-Free Survival*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / pathology